FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug-Eluting Peripheral Transluminal Angioplasty Catheter

PMA: P140010 · Supplement: S076 · Decision Oct 12, 2023
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Trade Name
IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter, IN.PACT 018 Paclitaxel-Coated
PMA Number
P140010
Supplement Number
S076
Device Class
FDA Class 3
Product Code
ONU
Generic Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
October 12, 2023
Date Received
September 28, 2023
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

removal of operators’ hands/gloves testing from the environmental monitoring program for all devices, manufactured at Medtronic Ireland in controlled environment areas meeting ISO Class 8 requirements

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
ONU Drug-Eluting Peripheral Transluminal Angioplasty Catheter